Oppenheimer & Co.

Oppenheimer & Co. is out with a research report on Vistaprint N.V. (NASDAQ: VPRT) and it has a Perform rating on shares. In a note to clients, Oppenheimer & Co. writes, "Following Vistaprint's F1Q (Sept.) results, we are increasing our F12 non-GAAP EPS forecast to reflect share repurchases...

Oppenheimer & Co. is out with a research report on Simcere Pharmaceutical Group (NASDAQ: SPAR) and it has a Perform rating. In a note to clients, Oppenheimer & Co. writes, "SCR reported an 8.9% yoy sales decline due to under-performance of Edaravone and "other branded generics" (-20%yoy),...

Oppenheimer & Co. is out with a research report on AEterna Zentaris Inc. (NASDAQ: AEZS) and it has an Outperform rating and a $5 price target on shares. In a note to clients, Oppenheimer & Co. writes, "Earlier today AEZS reported financial results for 3Q11 and provided an update on its...

Oppenheimer & Co. is out with a research report on Mindray Medical Int'l Ltd. (NYSE: MR) and it has an Outperform rating and a $32 price target on shares. In a note to clients, Oppenheimer & Co. writes, "MR's 3Q11 revenue growth of 29.8% beat our/Street estimates of 16.7%/18.7% by a wide...

Oppenheimer & Co. is out with a research report on Kodiak Oil & Gas Corporation (NYSE: KOG) and it has an Outperform rating and a $7.50 price target on shares. In a note to clients, Oppenheimer & Co. writes, "KOG plans to complete 7.5 net wells during 4Q11, which we expect to result in...

Oppenheimer & Co. is out with a research report on Globe Specialty Metals, Inc. (NYSE: GSM) and it has an Outperform rating and a $26 price target on shares. In a note to clients, Oppenheimer & Co. writes, "GSM reports FY1Q12 results on 11/8. We believe there is potential upside to our...

Oppenheimer & Co. is out with a research report on MedAssets, Inc. (NASDAQ: MDAS) and it has an Outperform rating and a $20 price target on shares. In a note to clients, Oppenheimer & Co. writes, "For the third quarter in a row, MedAssets beat consensus. However, the company lowered the...

Oppenheimer & Co. is out with a research report on Amedisys, Inc. (NASDAQ: AMED) and it has an Outperform rating and a $15 price target after it reported earnings. In a note to clients, Oppenheimer writes, " Amedisys had another tough quarter, reporting a 3Q11 miss, and lowered 2011 EPS...

Oppenheimer & Co. is out with a research report on Generac (NASDAQ: GNRC) and it has an Outperform rating and a $28 price target on shares. In a note to clients, Oppenheimer & Co. writes, "GNRC reported 3Q adjusted EPS of $0.75, ahead of our $0.65 estimate and $0.63 consensus. Net sales of...

Oppenheimer & Co. is out with a research report on OpenTable, Inc. (NASDAQ: OPEN) and it has a $54 price target on shares, down from $93 after it reported earnings. In a note to clients, Oppenheimer & Co. writes, "While widely expected, we're reducing our 2011 estimates to reflect slowing...

Oppenheimer & Co. is out with a research report on Fiserv, Inc. (NASDAQ: FISV) and it has an Outperform rating and a $72 price target on shares. In a note to clients, Oppenheimer & Co. writes, "3Q11 EPS rose 12% Y/Y; in line with our estimate although revenue/margins fell shy of our...

Oppenheimer & Co. is out with a research report on Skilled Healthcare Group (NYSE: SKH) and it has an Outperform rating and a $10 price target on shares. In a note to clients, Oppenheimer & Co. writes, "SKH reported adjusted 3Q:11 EPS of $0.32 (GAAP: -$6.26), ahead of our estimate and...

Oppenheimer & Co. is out with a research report on Advanced Micro Devices (NYSE: AMD) and it has a Perform rating on shares. In a note to clients, Oppenheimer & Co. writes, "AMD reported 3Q sales/non-GAAP EPS of $1.69B/$0.15, slightly ahead of September's negative pre-announcement. NB, GPU...

Oppenheimer & Co. is out with a research report on Micros Systems Inc. (NASDAQ: MCRS) and is raising its price target to $57, and it has an Outperform rating on shares. In a note to clients, Oppenheimer & Co. writes, "MCRS built on its solid FY11 business momentum and started FY12 on the...

Oppenheimer & Co. is out with a research report on Titan International Inc. (NYSE: TWI) and it has a Perform rating on shares. In a note to clients, Oppenheimer & Co. writes, "Better-than-expected revenues—helped by strong Earthmoving/Construction results—were offset by greater-than-...